Reuters - It’s not just women who suffer from urinary incontinence: Nearly one in twenty U.S. men have moderate to severe forms of the condition, which is as common as one in six among elderly men, a new study finds.
Disabled Handicapped Network Elderly Senior Adult
Reuters - It’s not just women who suffer from urinary incontinence: Nearly one in twenty U.S. men have moderate to severe forms of the condition, which is as common as one in six among elderly men, a new study finds.
AP - Certified nursing assistant Brenda Chaney was on duty in an Indiana nursing home one day when she discovered a patient lying on the floor, unable to stand.
Reuters - The U.S. Food and Drug Administration said on Friday it will examine the potential heart risks of Novartis AG’s Parkinson’s drug Stalevo, a combination of two treatments for the debilitating brain disease.
AP - The fear of falling may be enough to make elderly people more likely to fall, regardless of their actual risk, a new study says.
Reuters - Medical emergencies on commercial airplanes are not common, but certain passengers — including the elderly and pregnant women — face greater risks of complications requiring flight diversions, a study of one airline finds.
HealthDay - FRIDAY, Aug. 20 (HealthDay News) — Older people who have a fear
of falling are at increased risk for future falls, regardless of their
actual risk of tumbling, a new study finds.
Reuters - U.S. health officials said on Wednesday they expect Medicare patients enrolled in the federal health insurance program’s prescription drug benefit to see their premium costs remain flat next year.
Reuters - Scientists reported on Tuesday they have some of the best evidence yet to support long-held theories that repeated blows to the head may cause nerve-degenerative diseases like Lou Gehrig’s disease and Alzheimer’s.
Reuters - Eli Lilly and Co halted development of an Alzheimer’s drug after it worsened patients’ symptoms in late-stage studies, dealing a fresh blow to the U.S. drugmaker and to research to fight the disease.
Reuters - Eli Lilly and Co is halting development of one of its experimental late-stage Alzheimer’s disease treatments after preliminary results from large studies showed the drug was linked to worsening of cognition and the ability to perform daily tasks.